SALT LAKE CITY, April 20 /PRNewswire/ -- ZARS Pharma, Inc. announced today that Robert Lippert, President and CEO, is scheduled to present a corporate overview at Deutsche Bank Securities' Health Care Conference on Tuesday, May 2, 2006 at 7:30 a.m. Eastern Time at the Sheraton Boston Hotel in Boston, MA.
About ZARS Pharma, Inc.:
ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of patented technologies that deliver drugs into and across the skin. The Company's primary therapeutic targets are pain management and dermatology.
More information about the Company and its technology can be found on its web site at http://www.zars.com.
ZARS Pharma, Inc.
CONTACT: Gregory S. Ayers, Chief Financial Officer of ZARS Pharma, Inc.,+1-801-350-0202